AFMD
Affimed N.V.
NASDAQ · Healthcare · Biotechnology · DE
$0.18
+0.00%Margins
Gross margin
100.0%
EBITDA margin
-7433.0%
EBIT margin
-8005.2%
Net margin
-7978.3%
FCF margin
-8829.9%
-406.9%
Return on equity
-175.1%
Return on assets
-233.4%
Return on invested capital
0.02x
Asset turnover
-$89.4M
Cash from operations
$1.80
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2024